Pathological Complete Response and ctDNA Analyses Results from a Randomized Phase III Trial of Neoadjuvant Chemotherapy or Chemoradiotherapy plus Sintilimab vs. Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S106-S107
DOI: 10.1016/j.ijrobp.2026.06.142 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von J. Lv und 22 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lv, J., Leng, X., Gong, L., Wenwu, H., Chen, Y., Hu, W., Xian, L., Hu, T., Zhou, H., Zheng, Y., Wong, I., Zhang, W., Li, F., Li, Q., Xie, L., Zheng, X., Bai, H., Qing, H., Zhou, Y., …, & Zhang, S. (2026). Pathological Complete Response and ctDNA Analyses Results from a Randomized Phase III Trial of Neoadjuvant Chemotherapy or Chemoradiotherapy plus Sintilimab vs. Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics, 126(1), S106-S107. https://doi.org/10.1016/j.ijrobp.2026.06.142
Vancouver
Lv J, Leng X, Gong L, Wenwu H, Chen Y, Hu W, et al. Pathological Complete Response and ctDNA Analyses Results from a Randomized Phase III Trial of Neoadjuvant Chemotherapy or Chemoradiotherapy plus Sintilimab vs. Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S106-S107. doi:10.1016/j.ijrobp.2026.06.142
BibTeX
@article{Lv2026,
author = {Lv, J. and Leng, X. and Gong, L. and Wenwu, H. and Chen, Y. and Hu, W. and Xian, L. and Hu, T. and Zhou, H. and Zheng, Y. and Wong, I.Y.H. and Zhang, W. and Li, F. and Li, Q. and Xie, L. and Zheng, X. and Bai, H. and Qing, H. and Zhou, Y. and Lin, T. and Tang, P. and Han, Y. and Zhang, S.},
title = {Pathological Complete Response and ctDNA Analyses Results from a Randomized Phase III Trial of Neoadjuvant Chemotherapy or Chemoradiotherapy plus Sintilimab vs. Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S106--S107},
doi = {10.1016/j.ijrobp.2026.06.142}
}
EUVIMED